Krystal Biotech buy Chardan Capital

Summary

This prediction ended on 13.12.25 with a price of €208.10. The BUY prediction by Chardan_Capital finished with a performance of 25.47%. Chardan_Capital has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Chardan_Capital has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Krystal Biotech	-3.185%	-3.185%	139.645%
iShares Core DAX®	-1,11 %	0,20 %	1,21 %
iShares Nasdaq 100	-4,35 %	-3,25 %	25,87 %
iShares Nikkei 225®	-6,79 %	-7,72 %	50,97 %
iShares S&P 500	-1,79 %	0,99 %	21,07 %